Using Cellular Immunotherapies to Induce Durable Objective Responses in Cancer Patients

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Using Cellular Immunotherapies to Induce Durable Objective Responses in Cancer Patients

By University of Louisville FEATURING Jason Chesney

0 views

May 18, 2023

Jason A. Chesney, M.D., Ph.D., Professor of Medicine, Pharmacology and Toxicology, Biochemistry and Molecular Biology; ...
read more ↘ Chief, Division of Medical Oncology and Hematology; James Graham Brown Foundation Chair; Associate Vice President for Health Affairs; Director and Chief Administrative Officer, UofL Health - James Graham Brown Cancer Center; and Co-Director, Center for Cancer Immunology and Immunotherapy at the University of Louisville School of Medicine, focused on understanding the concept of using the immune system to induce objective responses in cancer patients, recognizing the clinical utility of Tumor Infiltrating Lymphocytes (TILs) for the treatment of multiple types of cancer, and discussing the clinical utility of Chimeric Antigen Receptor (CAR) T cells for the treatment of multiple types of cancer.
↖ read less

Comments 0